WebJan 5, 2024 · Idiopathic pulmonary fibrosis (IPF) is the most common ILD with unknown clinical origin. The characteristic morphological feature of IPF is a steroid-resistant disease which pertains to a relatively poor prognosis. The prevalence of IPF is reported to range ~30 cases per 100,000 adults. WebPurpose: We evaluated the risk and potential benefit of high-dose corticosteroid therapy in patients with idiopathic pulmonary fibrosis. Subjects and methods: We prospectively …
Treatment of idiopathic pulmonary fibrosis - UpToDate
WebJan 5, 2024 · Idiopathic pulmonary fibrosis (IPF) is the most common ILD with unknown clinical origin. The characteristic morphological feature of IPF is a steroid-resistant … A retrospective review was performed of the files of consecutive patients with IPF who were admitted to the Kindai University Hospital for their first AE between January 2008 and December 2024 and were discharged alive. Whether or not the patient developed a recurrent AE within 1 year from the date of … See more Pulmonary function test results that were obtained during the stable phase of the disease within 1 year prior to the AE were adopted as baseline values. Pulmonary function testing was … See more The recurrence of an AE-IPF within 1 year after the date of admission for the first AE-IPF was reviewed in each patient. The time to recurrence was defined as the number of days from the date … See more The following baseline characteristics of the patients with AE-IPF were determined, as follows: gender, age, body mass index, smoking status, long … See more The total dose and the total dose per body weight (kg) of corticosteroids administered over each month after the initiation of steroid therapy were evaluated. Whether or … See more blue vs yellow ethernet cable
National Center for Biotechnology Information
WebMay 1, 2024 · We made a diagnosis of post-COVID-19 pulmonary fibrosis—an emerging new diagnosis in the COVID era that has been described in case reports. 1–3 Schwensen et al. 2 described an 80-year-old woman who died from respiratory failure secondary to extensive fibrosis and traction bronchiectasis is seen on CT chest about five weeks into … WebNon-steroid agents for idiopathic pulmonary fibrosis. Idiopathic pulmonary fibrosis is a form of progressive lung disease which ultimately leads to death. The cause is unknown, … WebMar 1, 2001 · Corticosteroids have been the mainstay of therapy for idiopathic pulmonary fibrosis since the 1950s (1).However, the efficacy of steroid therapy is now being … blue vs yellow flame